Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Sells C$224,847.00 in Stock

Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Regan Stewart sold 6,300 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of C$35.69, for a total transaction of C$224,847.00.

Regan Stewart also recently made the following trade(s):

• On Friday, November 15th, Regan Stewart sold 1,637 shares of Jamieson Wellness stock. The shares were sold at an average price of C$35.67, for a total value of C$58,384.75.
• On Monday, August 26th, Regan Stewart sold 8,732 shares of Jamieson Wellness stock. The shares were sold at an average price of C$31.65, for a total transaction of C$276,373.04.

Jamieson Wellness Price Performance

TSE JWEL opened at C$36.60 on Tuesday. Jamieson Wellness Inc. has a 12 month low of C$23.98 and a 12 month high of C$36.98. The company has a debt-to-equity ratio of 92.76, a current ratio of 3.21 and a quick ratio of 1.08. The company’s 50 day simple moving average is C$34.73 and its 200 day simple moving average is C$31.32. The firm has a market capitalization of C$1.52 billion, a PE ratio of 42.56 and a beta of 0.63.

Jamieson Wellness Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Friday, December 13th will be given a $0.21 dividend. The ex-dividend date of this dividend is Friday, November 29th. This is a boost from Jamieson Wellness’s previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 2.30%. Jamieson Wellness’s payout ratio is 97.67%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Royal Bank of Canada upped their price target on Jamieson Wellness from C$37.00 to C$38.00 in a report on Friday, November 8th. Canaccord Genuity Group lifted their price target on Jamieson Wellness from C$32.50 to C$36.25 in a research note on Friday, August 9th. National Bankshares boosted their target price on shares of Jamieson Wellness from C$36.50 to C$42.00 in a research note on Monday. TD Securities upped their target price on Jamieson Wellness from C$40.00 to C$42.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, BMO Capital Markets increased their price objective on shares of Jamieson Wellness from C$35.00 to C$42.00 in a report on Friday, August 9th.

About Jamieson Wellness

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.